Carret Asset Management, LLC Illumina, Inc. Transaction History

Carret Asset Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 18, 2024	SELL	$127.73 - $147.2 $47,898 - $55,199	-375 Reduced 20.38%	1,465 $201,000
Q4 2023 Feb 02, 2024	SELL	$92.79 - $142.53 $8,815 - $13,540	-95 Reduced 4.91%	1,840 $256,000
Q3 2023 Oct 12, 2023	BUY	$128.91 - $192.44 $74,123 - $110,653	575 Added 42.28%	1,935 $265,000
Q2 2023 Jul 25, 2023	BUY	$183.43 - $232.67 $23,845 - $30,247	130 Added 10.57%	1,360 $254,000
Q1 2023 May 11, 2023	SELL	$193.75 - $232.55 $968 - $1,162	-5 Reduced 0.4%	1,230 $286,000
Q4 2022 Jan 10, 2023	BUY	$187.24 - $242.74 $231,241 - $299,783	1,235 New	1,235 $250,000
Q2 2022 Aug 04, 2022	SELL	$181.58 - $368.0 $149,803 - $303,600	-825 Closed	0 $0
Q1 2022 Apr 13, 2022	BUY	$303.87 - $423.8 $50,138 - $69,927	165 Added 25.0%	825 $288,000
Q2 2021 Jul 14, 2021	BUY	$372.84 - $481.5 $24,234 - $31,297	65 Added 10.92%	660 $312,000
Q1 2021 Jul 14, 2021	BUY	$361.28 - $504.76 $5,419 - $7,571	15 Added 2.59%	595 $229,000
Q4 2020 Mar 16, 2021	BUY	$292.7 - $370.96 $169,766 - $215,156	580 New	580 $215,000

901

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.7B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Carret Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Carret Asset Management, LLC with notifications on news.